About this Event
Ever wonder how a global biopharma giant “PLai”s with AI to transform R&D strategy?
Get ready to be inspired by the ingenious ways Sanofi integrates AI-driven insights to accelerate innovation and drive portfolio success.
Join SDP Boston on April 29 at 6:00 PM at MIT Sloan to hear from Dr. Helen Merianos, SVP and Global Head of R&D Strategy and Portfolio Management at Sanofi, as she showcases how her team’s pioneering work is reshaping R&D and portfolio strategy in one of the world’s leading healthcare organizations.
About the Speaker:
Dr. Helen Merianos, SVP and Global Head of R&D Strategy and Portfolio Management at Sanofi.
As SVP, Global Head of R&D Strategy and Portfolio Management Helen is responsible for managing Sanofi’s innovative portfolio across R&D Pharma and Vaccines. Helen and her team lead the end-to-end strategic portfolio decision making, which enables portfolio trade-off decisions and improves strategic planning at a corporate level.
Helen joined Sanofi in 2021 as Head of Portfolio Decision Resources to lead a business transformation in portfolio decision making for R&D. She was promoted to Global Head of R&D Strategy and Portfolio Management where she has pioneered the use of PLai and AI to drive portfolio strategy.
Prior to joining Sanofi, Helen held positions of increasing responsibility at GSK for nearly 15 years leading teams working on commercial insights and valuation assessment, portfolio strategy, investment and prioritization, and clinical development and commercialization strategy. Before working in healthcare, Helen started her career at McKinsey & Co.
Helen holds a PhD in Biophysical Chemistry from Yale University.
What to Expect
Perspectives on using AI and advanced analytics to navigate complex R&D decisions and drive portfolio impact.
Strategies for training and empowering teams to adopt new technologies and foster a data-driven culture within large organizations.
Real-world insights into the organizational transformation behind bringing innovative solutions to market, faster.
Event Details:
- Date/Time: April 29, 6:00 PM
- Location: MIT Sloan, classroom E51-149
- Address: 70 Memorial Dr, Cambridge, MA
- Speaker: Dr. Helen Merianos (Sanofi)
- Topic: R&D Strategy & Portfolio Management with a focus on AI-driven innovation
Don’t miss this opportunity to connect with peers and discover how Sanofi and Dr. Merianos are turning data into decisions, “PLai”-fully pushing the boundaries of pharmaceutical innovation. For more details or to RSVP, please contact .
This session is sponsored by Intelligencia AI
Intelligencia AI de-risks decision-making in drug development by applying purpose-built AI tools and expertly curated data to assess the probability of a drug’s success. https://www.intelligencia.ai/
Agenda
🕑: 06:00 PM - 07:30 PM
R&D Strategy & Portfolio Management with a focus on AI-driven innovation
Host: Dr. Helen Merianos
Info: Ever wonder how a global biopharma giant “PLai”s with AI to transform R&D strategy?
Get ready to be inspired by the ingenious ways Sanofi integrates AI-driven insights to accelerate innovation and drive portfolio success.
Join SDP Boston on April 29 at 6:00 PM at MIT Sloan to hear from Dr. Helen Merianos, SVP and Global Head of R&D Strategy and Portfolio Management at Sanofi, as she showcases how her team’s pioneering work is reshaping R&D and portfolio strategy in one of the world’s leading healthcare organizations.
What to Expect
Perspectives on using AI and advanced analytics to navigate complex R&D decisions and drive portfolio impact.
Strategies for training and empowering teams to adopt new technologies and foster a data-driven culture within large organizations.
Real-world insights into the organizational transformation behind bringing innovative solutions to market, faster.
Event Venue & Nearby Stays
MIT Sloan School of Management, Building E51 (E51-315) 70 Memorial Dr, 70 Memorial Drive, Cambridge, United States
USD 0.00
